Nivolumab in the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (RM-SCCHN): A Report of 16 Cases at a Single Institution

Practica Oto-Rhino-Laryngologica ◽

10.5631/jibirin.112.625 ◽

2019 ◽

Vol 112 (9) ◽

pp. 625-628

Author(s):

Tomoko Yamazaki ◽

Satoshi Saijo ◽

Keitaro Fujii ◽

Takayuki Imai ◽

Yukinori Asada ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Single Institution ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyp002 ◽

2009 ◽

Vol 39 (4) ◽

pp. 225-230 ◽

Author(s):

N. Kiyota ◽

M. Tahara ◽

S. Kadowaki ◽

N. Fuse ◽

T. Doi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Systemic Chemotherapy ◽

Efficacy And Safety ◽

Single Institution ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Results of Tpex (Docetaxel, Cisplatin, Cetuximab) Regimen Use in First Line Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M Scchn) in a Single Institution

Annals of Oncology ◽

10.1093/annonc/mdu340.12 ◽

2014 ◽

Vol 25 ◽

pp. iv344 ◽

Author(s):

C. Even ◽

B. Bobillot ◽

L. Mayache-Badis ◽

F.R. Ferrand ◽

N. Lezghed ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Single Institution ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14264023.15777137 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Clinical Activity ◽

Molecular Response ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954085.793459863 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Proteasome Inhibitor ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Download Full-text

Faculty Opinions recommendation of Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954885.793461177 ◽

2012 ◽

Author(s):

Sandra Nuyts

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Preclinical Data ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Comparison of second-line treatments of recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734912521.793555705 ◽

2019 ◽

Author(s):

Ricardo Hitt

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Second Line ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

MO3-2 Prognostic significance of metastatic sites in recurrent or metastatic squamous cell carcinoma of the head and neck

Annals of Oncology ◽

10.1016/j.annonc.2021.05.565 ◽

2021 ◽

Vol 32 ◽

pp. S296

Author(s):

Ari Nishimura ◽

Tomoya Yokota ◽

Yoshiyuki Iida ◽

Tomoyuki Kamijo ◽

Takashi Mukaigawa ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Prognostic Significance ◽

Metastatic Squamous Cell Carcinoma ◽

Metastatic Sites

Download Full-text

A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix

European Journal of Cancer ◽

10.1016/j.ejca.2004.12.013 ◽

2005 ◽

Vol 41 (4) ◽

pp. 523-530 ◽

Author(s):

Jennifer J. Knox ◽

Lillian L. Siu ◽

Eric Chen ◽

Jim Dimitroulakos ◽

Suzanne Kamel-Reid ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Prolonged Administration ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck

Head & Neck ◽

10.1002/hed.25636 ◽

2019 ◽

Vol 41 (6) ◽

pp. 1895-1902 ◽

Author(s):

Aurora Mirabile ◽

Rosalba Miceli ◽

Rosa Gioia Calderone ◽

Laura Locati ◽

Paolo Bossi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Prognostic Factors ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Observational study of the cetuximab relative dose intensity (RDI) in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Data on the maintenance and every two weeks use (DIRECT study)

Annals of Oncology ◽

10.1093/annonc/mdw376.19 ◽

2016 ◽

Vol 27 ◽

pp. vi334 ◽

Author(s):

J. Guigay ◽

E. Chamorey ◽

P. Céruse ◽

F. Mornex ◽

M. Degardin ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Observational Study ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Dose Intensity ◽

Line Treatment ◽

Metastatic Squamous Cell Carcinoma ◽

First Line Treatment

Download Full-text